RPRX
Royalty Pharma Plc
NASDAQ · Healthcare · Biotechnology · US
$67.30
−0.40%0
Insider buys (3m)
7
Insider sells (3m)
-$13.0M
Net value (3m)
+19.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 5, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 4,126 | $57 |
| Sep 30, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 4,126 | $58 |
| Sep 30, 2026 | Bassler Bonnie L · director | A-Award | 642 | $58 |
| Sep 24, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 3,927 | $59 |
| Sep 24, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 96,073 | $59 |
| Aug 19, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 100,000 | $60 |
| Aug 17, 2026 | Coyne Terrance P. · officer: EVP & CFO | Sale | 1,772 | $59 |
| Aug 17, 2026 | Coyne Terrance P. · officer: EVP & CFO | Sale | 9,230 | $59 |
| Aug 7, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | A-Award | 11,002 | $0.00 |
| Aug 7, 2026 | Coyne Terrance P. · officer: EVP & CFO | A-Award | 11,002 | $0.00 |
| Aug 7, 2026 | Legorreta Pablo G. · director, officer: CEO, Chairman of the Board | A-Award | 65,216 | $0.00 |
| Aug 7, 2026 | Urist Marshall · officer: EVP, Research & Investments | A-Award | 8,252 | $0.00 |
| Jul 2, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 9,099 | $56 |
| Jun 30, 2026 | Bassler Bonnie L · director | A-Award | 689 | $54 |
| Jun 25, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 32,408 | $54 |
| Jun 25, 2026 | Hite Christopher · officer: EVP & Chairman, Partnering | Sale | 117,592 | $54 |
| Jun 25, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 9,098 | $55 |
| Jun 8, 2026 | Ho Carole · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | WEATHERMAN ELIZABETH H · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | HODGSON DAVID C · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Coric Vlad · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Norden Gregory · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Bassler Bonnie L · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | Engelbert Catherine M. · director | A-Award | 4,545 | $0.00 |
| Jun 8, 2026 | LOVE TED W · director | A-Award | 4,545 | $0.00 |
| May 28, 2026 | Coyne Terrance P. · officer: EVP & CFO | Sale | 64,399 | $54 |
| May 21, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 13,684 | $53 |
| May 15, 2026 | Norden Gregory · director | Sale | 3,045 | $53 |
| May 15, 2026 | Urist Marshall · officer: EVP, Research & Investments | Sale | 13,684 | $53 |
| May 8, 2026 | Legorreta Pablo G. · director, officer: CEO, Chairman of the Board | A-Award | 143,821 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 249Increased 535Reduced 382Sold out 55
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 44,110,365 | Nov 5, 2026 |
| MORGAN STANLEY | Reduced | 43,571,633 | May 15, 2026 |
| FMR LLC | Increased | 42,957,880 | Nov 5, 2026 |
| MORGAN STANLEY | Reduced | 42,931,597 | Aug 13, 2026 |
| FMR LLC | Reduced | 39,984,116 | Nov 5, 2026 |
| FMR LLC | Increased | 39,404,093 | Nov 5, 2026 |
| FMR LLC | Increased | 35,953,354 | Nov 5, 2026 |
| Capital International Investors | Increased | 35,273,770 | Aug 12, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Increased | 35,005,736 | May 13, 2026 |
| FMR LLC | Reduced | 33,884,250 | Nov 5, 2026 |
| FMR LLC | Increased | 33,634,216 | Nov 5, 2026 |
| FMR LLC | Increased | 31,583,929 | Nov 5, 2026 |
| FMR LLC | Reduced | 30,427,172 | Nov 5, 2026 |
| FMR LLC | Increased | 28,205,161 | Nov 5, 2026 |
| FMR LLC | Increased | 27,890,143 | Nov 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 5, 2026